Boehringer Ingelheim to present highly anticipated data from landmark TIOSPIR ™ trial, and their respiratory pipeline products in COPD, asthma, IPF and lung cancer at ERS 2013

Boehringer Ingelheim to present highly anticipated data from landmark TIOSPIR ™ trial, and their respiratory pipeline products in COPD, asthma, IPF and lung cancer at ERS 2013
Source: Boehringer Ingelheim Corporate News - Category: Research Source Type: news